Technology News and Research

RSS

DePuy Synthes inks sales agreement with Radlink to offer real-time image guidance with hip replacement systems

DePuy Synthes Companies has signed an exclusive worldwide sales agreement with Radlink, Inc., an emerging global leader in advanced medical imaging technology, to offer real-time image guidance with its hip replacement systems. The agreement further demonstrates DePuy Synthes Companies’ ongoing commitment to help improve patient outcomes, increase patient satisfaction and reduce costs.

27 Mar 2015

TeleHealth Services, Samsung complete new SmarTigr system to improve patient-provider communication

TeleHealth Services, the nation’s leading provider of hospital televisions and interactive patient engagement solutions, announced through their partnership with Samsung Electronics America, Inc., the completion of a new patient engagement solution called SmarTigr.

27 Mar 2015

LifeCodexx announces promising results from proof-of-principle study of qPCR-based NIPT assay

LifeCodexx AG today reports the successful outcome of a proof-of-principle of its novel assay for non-invasive prenatal testing (NIPT assay) based on quantitative real-time PCR (qPCR). This NIPT assay, designed to determine fetal aneuploidies from maternal blood, will offer significant advantages, such as enhanced test performance at affordable prices, over other prenatal examination methods.

27 Mar 2015

Philip Low to be recognized with AACR Award for Outstanding Achievement in Chemistry in Cancer Research

The American Association for Cancer Research will recognize Philip S. Low, PhD, with the ninth annual AACR Award for Outstanding Achievement in Chemistry in Cancer Research at the AACR Annual Meeting 2015, to be held in Philadelphia, April 18-22.

26 Mar 2015

Aridis Pharmaceuticals begins Aerucin Phase 1 clinical study for treatment of acute pneumonia

Aridis Pharmaceuticals, Inc., a biopharmaceutical company applying proprietary technologies to produce novel therapies for infectious diseases, announced today the initiation of a Phase 1 clinical study of Aerucin, the Company's fully human IgG1 monoclonal antibody (mAb) against Pseudomonas aeruginosa bacteria, which is being developed as an adjunctive treatment for acute pneumonia.

26 Mar 2015

Zimmer celebrates significant testing milestone for Vivacit-E Vitamin E Technology

Zimmer Holdings, Inc. is highlighting its Vivacit-E Advanced Bearing Technology with Vitamin E by celebrating a significant testing milestone.

26 Mar 2015

Wyatt Technology’s CG-MALS system enables characterization of complex protein-protein interactions

Study published in Nature outlines use of Wyatt’s Calypso II system to confirm the stoichiometry of αSNAP-SNARE complex

From Waters | Wyatt Technology 26 Mar 2015

Philips enters into collaboration with Janssen to develop new handheld blood test to support care of patients with neuropsychiatric disorders

Royal Philips today announced that it has entered into a multi-year development agreement with Janssen Pharmaceutica N.V. (Janssen).

From Philips Healthcare 26 Mar 2015

Cellworld 2015 conference to be held in Downtown San Francisco on Sept. 21-22, 2015

Finesse Solutions announced Cellworld 2015, a new event that is specifically designed for innovators, visionaries and senior executives in bio-processing.

26 Mar 2015

Iceland paint a genomic picture for an entire nation

Researchers in Iceland have published the largest ever studies of whole-genome data and effectively deduced the genetic code of “an entire nation.”

26 Mar 2015

USF scientists identify potential compounds to improve cardiovascular system, small vessel disease

University of South Florida scientists have identified a group of compounds with the potential for beneficial effects on the cardiovascular system and small vessel disease while researching grape seed extracts discovered at USF.

26 Mar 2015

Rice University study reveals carbon nanotube fibers can provide two-way connection with neurons

Carbon nanotube fibers invented at Rice University may provide the best way to communicate directly with the brain.

26 Mar 2015

Position statement on promise, challenges of non-invasive prenatal testing

Two of the world's largest professional societies of human geneticists have issued a joint position statement on the promise and challenges of non-invasive prenatal testing (NIPT), a new procedure to test blood drawn from pregnant mothers for Down syndrome and other chromosomal disorders in the fetus.

26 Mar 2015

Bioquell QUBE to be showcased at EAHP 2015

The latest generation isolator, the Bioquell QUBE, will be showcased on stand 117 at the European Association of Hospital Pharmacists 20th annual conference in Hamburg, 25th to 27th March 2015.

26 Mar 2015

Challenges facing scientific community in the 21st century

Embracing revolutionary new techniques and answering questions about research funding are just two of the challenges facing the scientific community in the 21st century.

26 Mar 2015

K2M announces enhanced complex spine portfolio with addition of its innovative NILE™ alternative fixation spinal system

NILE features low-profile, robust implants and intuitive and light ergonomic instruments, intended to provide stabilization between the spine and the rod, and to allow for reduction, translation, compression and distraction while sparing the anatomy...

26 Mar 2015

Research opens door to new prostate cancer treatment

Researchers from the Centenary Institute’s Origins of Cancer Program have discovered new links between nutrition and prostate cancer.

26 Mar 2015

AstraZeneca, HSCI collaborate to find new treatments for diabetes

AstraZeneca today announced that it has entered into a five-year research collaboration with the Harvard Stem Cell Institute to adapt a technique that creates human beta cells from stem cells for use in screens of AstraZeneca’s compound library in the search for new treatments for diabetes.

26 Mar 2015

C3BS plans to open new U.S.-based facility to manufacture C-Cure for use in Phase III trial

Cardio3 BioSciences, a leader in the discovery and development of engineered cell therapies, today confirmed plans to open a new U.S.-based manufacturing facility in Rochester, Minnesota. The facility will support the Company’s current and anticipated manufacturing needs in the United States for both the Phase III clinical trial evaluating lead cardiovascular product candidate C-Cure (CHART-2), and its recently acquired CAR T-cell therapies’ portfolio.

26 Mar 2015

Theravectys gets authorization to produce lentiviral vectors for clinical use and CAR-T cell-based immunotherapy

THERAVECTYS, a clinical development biotechnology company that focuses on the development of therapeutic vaccines and immunotherapies, proudly announces that its manufacturing plant has obtained the status of a pharmaceutical manufacturing establishment, granted by the French National Agency for Medicines and Health Products Safety.

26 Mar 2015

Technology News and Research

DePuy Synthes inks sales agreement with Radlink to offer real-time image guidance with hip replacement systems

TeleHealth Services, Samsung complete new SmarTigr system to improve patient-provider communication

LifeCodexx announces promising results from proof-of-principle study of qPCR-based NIPT assay

Philip Low to be recognized with AACR Award for Outstanding Achievement in Chemistry in Cancer Research

Aridis Pharmaceuticals begins Aerucin Phase 1 clinical study for treatment of acute pneumonia

Zimmer celebrates significant testing milestone for Vivacit-E Vitamin E Technology

Wyatt Technology’s CG-MALS system enables characterization of complex protein-protein interactions

Philips enters into collaboration with Janssen to develop new handheld blood test to support care of patients with neuropsychiatric disorders

Cellworld 2015 conference to be held in Downtown San Francisco on Sept. 21-22, 2015

Iceland paint a genomic picture for an entire nation

USF scientists identify potential compounds to improve cardiovascular system, small vessel disease

Rice University study reveals carbon nanotube fibers can provide two-way connection with neurons

Position statement on promise, challenges of non-invasive prenatal testing

Bioquell QUBE to be showcased at EAHP 2015

Challenges facing scientific community in the 21st century

K2M announces enhanced complex spine portfolio with addition of its innovative NILE™ alternative fixation spinal system

Research opens door to new prostate cancer treatment

AstraZeneca, HSCI collaborate to find new treatments for diabetes

C3BS plans to open new U.S.-based facility to manufacture C-Cure for use in Phase III trial

Theravectys gets authorization to produce lentiviral vectors for clinical use and CAR-T cell-based immunotherapy

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News